Eval:

M1234 Analysis

Information

Study : 12345
Indication : Advanced Solid Tumor
Study start Date : 08th Nov 2024
Cut-off : 12th Dec 2024 DSUR
AE special interest information

Image loading

—- This is the image —-
Fig

Figure of Solid Tumor
Figure of Solid Tumor

In line coding

Adverse Events that occured to more than 5 subjects are ABDOMINAL DISCOMFORT, ACROCHORDON EXCISION, ACTINIC KERATOSIS, ALCOHOL USE, ALLERGIC GRANULOMATOUS ANGIITIS

Dataset

Interactive

to learn about more extension Click here 😊

Static

STUDYID USUBJID SUBJID RFSTDTC RFENDTC RFXSTDTC RFXENDTC RFICDTC RFPENDTC DTHDTC DTHFL SITEID AGE AGEU SEX RACE ETHNIC ARMCD ARM ACTARMCD ACTARM COUNTRY DMDTC DMDY TRT01P TRT01A TRTSDTM TRTSTMF TRTEDTM TRTETMF TRTSDT TRTEDT TRTDURD SCRFDT EOSDT EOSSTT FRVDT RANDDT DTHDT DTHDTF DTHADY LDDTHELD DTHCAUS DTHDOM DTHCGR1 LSTALVDT SAFFL RACEGR1 AGEGR1 REGION1 LDDTHGR1 DTH30FL DTHA30FL DTHB30FL
CDISCPILOT01 01-701-1015 1015 2014-01-02 2014-07-02 2014-01-02 2014-07-02 NA 2014-07-02T11:45 NA NA 701 63 YEARS F WHITE HISPANIC OR LATINO Pbo Placebo Pbo Placebo USA 2013-12-26 -7 Placebo Placebo 2014-01-02 H 2014-07-02 23:59:59 H 2014-01-02 2014-07-02 182 NA 2014-07-02 COMPLETED NA 2014-01-02 NA NA NA NA NA NA NA 2014-07-02 Y White 18-64 NA NA NA NA NA
CDISCPILOT01 01-701-1023 1023 2012-08-05 2012-09-02 2012-08-05 2012-09-01 NA 2013-02-18 NA NA 701 64 YEARS M WHITE HISPANIC OR LATINO Pbo Placebo Pbo Placebo USA 2012-07-22 -14 Placebo Placebo 2012-08-05 H 2012-09-01 23:59:59 H 2012-08-05 2012-09-01 28 NA 2012-09-02 DISCONTINUED 2013-02-18 2012-08-05 NA NA NA NA NA NA NA 2012-09-02 Y White 18-64 NA NA NA NA NA
CDISCPILOT01 01-701-1028 1028 2013-07-19 2014-01-14 2013-07-19 2014-01-14 NA 2014-01-14T11:10 NA NA 701 71 YEARS M WHITE NOT HISPANIC OR LATINO Xan_Hi Xanomeline High Dose Xan_Hi Xanomeline High Dose USA 2013-07-11 -8 Xanomeline High Dose Xanomeline High Dose 2013-07-19 H 2014-01-14 23:59:59 H 2013-07-19 2014-01-14 180 NA 2014-01-14 COMPLETED NA 2013-07-19 NA NA NA NA NA NA NA 2014-01-14 Y White >64 NA NA NA NA NA
CDISCPILOT01 01-701-1033 1033 2014-03-18 2014-04-14 2014-03-18 2014-03-31 NA 2014-09-15 NA NA 701 74 YEARS M WHITE NOT HISPANIC OR LATINO Xan_Lo Xanomeline Low Dose Xan_Lo Xanomeline Low Dose USA 2014-03-10 -8 Xanomeline Low Dose Xanomeline Low Dose 2014-03-18 H 2014-03-31 23:59:59 H 2014-03-18 2014-03-31 14 NA 2014-04-14 DISCONTINUED 2014-09-15 2014-03-18 NA NA NA NA NA NA NA 2014-04-14 Y White >64 NA NA NA NA NA
CDISCPILOT01 01-701-1034 1034 2014-07-01 2014-12-30 2014-07-01 2014-12-30 NA 2014-12-30T09:50 NA NA 701 77 YEARS F WHITE NOT HISPANIC OR LATINO Xan_Hi Xanomeline High Dose Xan_Hi Xanomeline High Dose USA 2014-06-24 -7 Xanomeline High Dose Xanomeline High Dose 2014-07-01 H 2014-12-30 23:59:59 H 2014-07-01 2014-12-30 183 NA 2014-12-30 COMPLETED NA 2014-07-01 NA NA NA NA NA NA NA 2014-12-30 Y White >64 NA NA NA NA NA
CDISCPILOT01 01-701-1047 1047 2013-02-12 2013-03-29 2013-02-12 2013-03-09 NA 2013-07-28 NA NA 701 85 YEARS F WHITE NOT HISPANIC OR LATINO Pbo Placebo Pbo Placebo USA 2013-01-22 -21 Placebo Placebo 2013-02-12 H 2013-03-09 23:59:59 H 2013-02-12 2013-03-09 26 NA 2013-03-29 DISCONTINUED 2013-07-28 2013-02-12 NA NA NA NA NA NA NA 2013-04-07 Y White >64 NA NA NA NA NA

Plots

Loops

01-701-1015

Adverse events : APPLICATION SITE ERYTHEMA APPLICATION SITE PRURITUS DIARRHOEA

01-701-1023

Adverse events : ERYTHEMA ERYTHEMA ERYTHEMA ATRIOVENTRICULAR BLOCK SECOND DEGREE

01-701-1028

Adverse events : APPLICATION SITE ERYTHEMA APPLICATION SITE PRURITUS

01-701-1033

Adverse events :

01-701-1034

Adverse events : APPLICATION SITE PRURITUS FATIGUE